Role of kinin and prostaglandin in cutaneous thermal nociception

International Immunopharmacology

Volumn 2, Issue 13-14, 2002, Pages 2005-2012

  Matsuzaki, Shigeyuki ^a   Hayashi, Izumi ^a   Nara, Yoshihiro ^a   Kamata, Kazuhisa ^a   Yamanaka, Mariko ^a   Okamoto, Hirotsugu ^a   Hoka, Sumio ^a   Majima, Masataka ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bradykinin; Brown Norway Katholiek rat; Hyperalgesia; Lipopolysaccharide; Prostaglandin; Thermal nociception

Indexed keywords

3 (6 ACETAMIDO 3 PYRIDYL) N [N [2,4 DICHLORO 3 [(2 METHYL 8 QUINOLINYL)OXYMETHYL]PHENYL] N METHYLAMINOCARBONYLMETHYL]ACRYLAMIDE; ACETIC ACID; BRADYKININ ANTAGONIST; CAPTOPRIL; INDOMETACIN; KININ; LIPOPOLYSACCHARIDE; MOFEZOLAC; PROSTAGLANDIN; TILMACOXIB; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; KININOGEN; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS1 PROTEIN, MOUSE; PTGS1 PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SELECTIVITY; ESCAPE BEHAVIOR; HYPERALGESIA; INFLAMMATION; LATENT PERIOD; LIGHT; MALE; MOUSE; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; THERMAL STIMULATION; WITHDRAWAL REFLEX; ANIMAL; ANIMAL BEHAVIOR; BIOSYNTHESIS; BROWN NORWAY RAT; DRUG ANTAGONISM; HEAT; INSTITUTE FOR CANCER RESEARCH MOUSE; METABOLISM; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ESCAPE REACTION; HEAT; HYPERALGESIA; ISOENZYMES; KININOGENS; LIPOPOLYSACCHARIDES; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED ICR; PAIN MEASUREMENT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RATS; RATS, INBRED BN; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; SPECIES SPECIFICITY;

EID: 0036892474     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00187-X     Document Type: Article

References (43)

1. Steranka L.R., Manning D.C., DeHaas C.J., Ferkany J.W., Borosky S.A., Connor J.R.et al. Bradykinin as a pain mediator: receptors are localized to sensory neurones, and antagonists have analgesic actions. Proc. Natl. Acad. Sci. U. S. A. 85:1988;3245-3249.
2. Dray A., Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 16:1993;99-104.
3. Armstrong G., Jepson J.B., Keele C.A., Stwert J.M. Pain producing substance in human inflammatory exudates and plasma. J. Physiol. 135:1957;350-370.
4. Sicuteri F., Franciullacci F.M., Franchi G., Del Bianco P.L. Serotonin-bradykinin potentiation of the pain receptors in man. Life Sci. 4:1965;309-316.
5. Ferreira S.H. Prostaglandins, aspirin-like drugs and analgesia. Nat., New Biol. 240:1972;200-203.
6. Whalley E.T., Clegg S., Stewart J.M., Vavrek R.J. The effect of kinin agonists and antagonists on the pain response of human blister base. Naunyn-Schmiedeberg's Arch. Pharmacol. 226:1987;652-655.
7. Ferreira S.H., Lorenzetti B.B., Correa F.M.A. Central and peripheral antialgesic action of aspirin-like drugs. Eur. J. Pharmacol. 53:1978;39-48.
8. Ferreira S.H., Moncada S., Vane J.R. Prostaglandins and the mechanism of analgesia produced by aspirin-like drugs. Br. J. Pharmacol. 49:1973;86-97.
9. Taiwo Y.O., Levine J.D. Characterization of the arachidonic acid metabolites mediating bradykinin and noradrenaline hyperalgesia. Brain Res. 458:1988;402-406.
10. Dubuisson D., Dennis S.G. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain. 4:1977;161-174.
11. Koster R., Anderson M., DeBeer E.J. Acetic acid for analgesic screening. Fed. Proc. 18:1959;412.
12. Siegmund E., Cadmus R., Lu G. A method for evaluating both non-narcotic and narcotic analgesics. Proc. Soc. Exp. Biol. Med. 95:1957;729-731.
13. D'Amour F., Smith D. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
14. Woolfe G., MacDonald A. The evolution of the analgesic action of pethidine hydrochloride (Demerol). J. Pharmacol. Exp. Ther. 80:1944;300-307.
15. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. 4:1957;409-419.
16. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
17. Goto K., Ochi H., Yasunaga Y., Matsuyuki H., Imayoshi T., Kusuhara H.et al. Analgesic effect of mofezolac, a non-steroidal antiinflammatory drug, against phenylquinone-induced acute pain in mice. Prostaglandins Other Lipid Mediat. 56:1998;245-254.
18. Matsushita M., Masaki M., Yagi Y., Tanaka T., Wakitani K. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats. Inflamm. Res. 46:1997;461-466.
19. 2 receptor antagonist, FR173657. Br. J. Pharmacol. 120:1997;617-624.
20. Bennett G.J., Xie Y.-K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
21. Oh-ishi S., Satoh K., Hayashi I., Yamazaki K., Nakano T. Differences in prekallikrein and high molecular weight kininogen levels in two strains of Brown Norway rat (Kitasato strain and Katholiek strain). Thromb. Res. 28:1982;143-147.
22. Lewis G.P. Kinin in inflammation and tissue injury. Erdos E.G. Handbook of experimental pharmacology. vol. XXV:1970;516-530 Springer-Verlag, Berlin.
23. Leme G.J. Bradykinin system. Vane J.R., Ferreira S.H. Handbook of experimental pharmacology. vol. 50:1978;464-522 Springer-Verlag, Berlin.
24. Marceau F., Lussier A., Regoli D., Giroud J.P. Pharmacology of kinins: their relevance to tissue injury and inflammation. Gen. Pharmacol. 14:1983;209-229.
25. Proud D., Kaplan A.P. Kinin formation: mechanisms and role in inflammatory disorders. Annu. Rev. Immunol. 6:1988;49-83.
26. Steranka L.R., Burch R.M. Bradykinin antagonists in pain and inflammation. Burch R.M. Bradykinin antagonists: basic and clinical research. 1991;171-189 Marcel Dekker, New York.
27. Hayashi I., Hoshiko S., Makabe O., Oh-ishi S. A point mutation of alanine 163 to threonine is responsible for the defective secretion of high molecular weight kininogen by the liver of brown Norway Katholiek rats. J. Biol. Chem. 15:1993;17219-17224.
28. Hayashi I., Oh-ishi S. Plasma kininogen deficiency: associated defective secretion of kininogens by primary cultures of hepatocytes from brown Norway Katholiek rats. J. Biochem. (Tokyo). 113:1993;531-537.
29. Oh-ishi S., Hayashi I., Hayashi M., Yamaki K., Yamasu A., Nakano T.et al. Evidence for a role of the plasma kallikrein-kinin system in acute inflammation: reduced exudation during carrageenin- and kaolin-pleurisies in kininogen-deficient rats. Agents Actions. 18:1986;450-454.
30. Kusuhara H., Matsuyuki H., Okumoto T. Involvement of prostaglandins produced by cyclooxygenase-1 in murine visceronociception induced by phenylquinone. Prostaglandins Other Lipid Mediat. 55:1998;43-49.
31. Matsumoto H., Fujiyoshi T., Murakami M., Kudo I., Oh-ishi S. Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice. Eur. J. Pharmacol. 352:1998;47-52.
32. Euchenhofer C., Maihofner C., Brune K., Tegeder I., Geisslinger G. Differential effect of selective cyclooxygenase-2 (COX-2) inhibitor NS 398 and diclofenac on formalin-induced nociception in the rat. Neurosci. Lett. 248:1998;25-28.
33. Beck P.W., Handwerker H.O. Bradykinin and serotonin effects on various types of cutaneous nerve fibers. Pflugers Arch. 347:1974;209-222.
34. Baccaglini P.I., Hogan P.G. Some rat sensory neurones in culture express characteristics of differentiated pain sensory cells. Proc. Natl. Acad. Sci. U. S. A. 80:1983;594-598.
35. Farmer S.G., Burch R.M. Biochemical and molecular pharmacology of kinin receptors. Annu. Rev. Pharmacol. Toxicol. 32:1992;511-536.
36. Hall J.M. Bradykinin receptors: pharmacological properties and biological roles. Pharmacol. Ther. 56:1992;131-190.
37. Hess J., Borkowskyi J., Young G., Strader C., Ranson R. Cloning and pharmacological characterization of a human bradykinin (bradykinin-2) receptor. Biochem. Biophys. Res. Commun. 184:1992;260-268.
38. 1 bradykinin receptor. J. Biol. Chem. 269:1994;1583-1586.
39. Nagy I., Pabla R., Matesz C., Dray A., Woolf C.J., Urban L. Cobalt uptake enables identification of capsaicin- and bradykinin-sensitive subpopulations of rat dorsal root ganglion cells in vitro. Neuroscience. 56:1993;241-246.
40. Segond-Von-Banchet G., Petersen M., Heppelmann B. Bradykinin receptors in cultured rat dorsal ganglion cells: influence of length of time in culture. Neuroscience. 75:1996;1211-1218.
41. 2 receptor knockout mice. Neuropharmacology. 36:1997;1009-1017.
42. 1 bradykinin receptors and sensory neurones. Br. J. Pharmacol. 118:1996;1469-1476.
43. Smith C.J., Zhang Y., Koboldt C.M., Muhammad J., Zweifel B.S., Shaffer A.et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl. Acad. Sci. U. S. A. 95:1998;13313-13318.